Key Insights

Highlights

Success Rate

58% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

22.7%

5 terminated out of 22 trials

Success Rate

58.3%

-28.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results58% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (7)
P 1 (7)
P 2 (2)

Trial Status

Completed7
Terminated5
Recruiting4
Unknown3
Active Not Recruiting1
Suspended1

Trial Success Rate

58.3%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT04929015Not ApplicableSuspended

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

NCT04084249Not ApplicableActive Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT06715839Not ApplicableRecruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT05980416Phase 1Terminated

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

NCT03037385Phase 1Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03978078Not ApplicableRecruitingPrimary

A Clinicobiological Database in Metastatic Digestive Cancers

NCT03535727Phase 1Completed

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

NCT05160168Phase 1Terminated

A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT04493632Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

NCT03559543Phase 2Completed

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

NCT03549494Phase 2Completed

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

NCT06223230Not ApplicableRecruiting

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

NCT04456140Phase 1Completed

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

NCT03724071Phase 1Terminated

Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.

NCT04811833Withdrawn

Gastrointestinal Anastomosis Using MonoPlus® Suture

NCT04722055Completed

A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China

NCT05374369Completed

Retrospective Analysis of Colorectal Cancer Screening Results

NCT05238584Not ApplicableUnknown

Total Versus Partial Omentectomy in the Treatment of Gastric Cancer

NCT04133324Unknown

C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer

NCT04500990Unknown

MRI DWI None-Gaussian Model Predicting Early Response to Immunotherapy in Digestive System Malignancies: a Prospective Observational Study

Scroll to load more

Research Network

Activity Timeline